Analyst Ranking
Bottom 26%
#4130 out of 5542 analysts
Average Return
-0.05%
Win Rate
41%16 out of 39
Risk vs Reward
Poor
Good

Jason N. Butler's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Precigen IncPGEN
+109.63%$3.22$6.75
2025-08-19 -
2026-08-18
Buy
Precigen IncPGEN
+84.96%$3.89$7.20
2026-03-26 -
2026-10-15
Buy
Precigen IncPGEN
+56.41%$4.60$7.20
2026-05-14 -
2026-10-15
Buy
Achieve Life Sciences IncACHV
+51.85%$4.59$6.97
2025-11-25 -
2026-10-15
Buy
Cytokinetics IncCYTK
+43.89%$49.62$71.40
2025-09-02 -
2026-09-01
Buy

Jason N. Butler Analyst Color

Get additional color on Jason N. Butler's coverage of popular stocks

Jason N. Butler's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Rezolute IncRZLT
3Buy$15.00+284.62%Maintains
10 days ago
Acadia Pharmaceuticals IncACAD
5Buy$33.00+67.43%Maintains
21 days ago
Argenx SeARGX
3Buy$1,200.00+41.80%Maintains
2 months ago
Leonabio IncLONA
2Buy$17.00+221.36%Maintains
2 months ago
Halozyme Therapeutics IncHALO
1Buy$93.00-23.46%Maintains
2 months ago
Cytokinetics IncCYTK
2Buy$110.00+72.09%Maintains
2 months ago
Zevra Therapeutics IncZVRA
2Buy$28.00+172.64%Maintains
2 months ago
Abivax SaABVX
4Buy$187.00+102.42%Reiterates
3 months ago
Gh Research PLCGHRS
2Buy$39.00+107.34%Maintains
5 months ago
Precigen IncPGEN
3Buy$11.00+52.88%Maintains
5 months ago
Avalo Therapeutics IncAVTX
2Buy$55.00+357.95%Maintains
5 months ago
Prothena Corp Public Ltd CoPRTA
1Buy$20.00+135.29%Maintains
5 months ago
Cormedix IncCRMD
2Buy$19.00+154.69%Reiterates
6 months ago
Minerva Neurosciences IncNERV
1Buy$14.00+478.51%Initiates Coverage On
6 months ago
Nasus Pharma LtdNSRX
1Buy$18.00+468.72%Maintains
7 months ago
Esperion Therapeutics IncESPR
1Buy$5.00+57.23%Maintains
7 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$10.00+165.25%Maintains
8 months ago
Achieve Life Sciences IncACHV
1Buy$19.00+172.60%Initiates Coverage On
a year ago
Rapport Therapeutics IncRAPP
1Buy$80.00+170.54%Maintains
a year ago
Terawulf IncWULF
1Buy$22.00+74.33%Maintains
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.